NCT01449838View on ClinicalTrials.gov

Phase I Study of Colistin Methanesulfonate Sodium

PHASE1CompletedINTERVENTIONAL

Enrollment

22

Participants

Timeline

Start Date

October 23, 2010

Primary Completion Date

December 9, 2010

Study Completion Date

December 9, 2010

Conditions

Infections, Pseudomonas

Interventions

DRUG

Colistimethate sodium

active

DRUG

Saline

placebo

Trial Locations (1)

2031

GSK Investigational Site, Randwick

Sponsors

Lead Sponsor

GlaxoSmithKline

All Listed Sponsors

lead

GlaxoSmithKline

INDUSTRY

NCT01449838 - Phase I Study of Colistin Methanesulfonate Sodium | Biotech Hunter | Biotech Hunter